Colm Burke
Question:1364. Deputy Colm Burke asked the Minister for Health the status of Pembrolizumab, used in the treatment of triple negative breast cancer (details supplied); and if he will make a statement on the matter. [48793/23]
View answerTuesday, 7 November 2023
Questions (1364)
Written answers
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.